Back
Prelude Therapeutics Vs. Doximity Industry Stock Comparison
Sell
21
PRLD
Prelude Therapeutics
Last Price:
1.07
Seasonality Move:
21.44%
Buy
72
DOCS
Doximity
Last Price:
52.83
Seasonality Move:
-1.56%
Sell
21
Prelude Therapeutics (PRLD)
is a Sell
Is Prelude Therapeutics a Buy, Sell or Hold?
- The current Prelude Therapeutics [PRLD] share price is $1.15. The Score for PRLD is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- PRLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Doximity (DOCS)
is a Buy
Is Doximity a Buy, Sell or Hold?
- The current Doximity [DOCS] share price is $58.05. The Score for DOCS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- DOCS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRLD Stock Price Chart
What is Prelude Therapeutics's stock price today?
-
The Prelude Therapeutics share price today is $1.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRLD is experiencing selling pressure, which indicates risk of future bearish movement.
DOCS Stock Price Chart
PRLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 23.52 | Sell |
| Chaikin Money Flow: | -291757 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.25 - 1.87) | Sell |
| Bollinger Bands (100): | (1.97 - 5.39) | Sell |
DOCS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.42 | Buy |
| Relative Strength Index (14 RSI): | 77.36 | Buy |
| Chaikin Money Flow: | -1048040 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.03 - 50.05) | Buy |
| Bollinger Bands (100): | (28.79 - 43.83) | Buy |
PRLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.23 | Sell |
| 20-day SMA: | 1.47 | Sell |
| 50-day SMA: | 2.35 | Sell |
| 200-day SMA: | 3.87 | Sell |
| 8-day EMA: | 1.25 | Sell |
| 20-day EMA: | 1.48 | Sell |
| 50-day EMA: | 2.28 | Sell |
| 200-day EMA: | 3.59 | Sell |
DOCS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.68 | Buy |
| 20-day SMA: | 44.82 | Buy |
| 50-day SMA: | 42.35 | Buy |
| 200-day SMA: | 31.69 | Buy |
| 8-day EMA: | 51.24 | Buy |
| 20-day EMA: | 46.6 | Buy |
| 50-day EMA: | 42.49 | Buy |
| 200-day EMA: | 34.23 | Buy |
Prelude Therapeutics Earnings Growth & PRLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.31 per share.
Doximity Earnings Growth & DOCS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.25 per share.
Prelude Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Doximity Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||